Qiagen NV (WBO:QGE2)
€ 43.02 0.09 (0.21%) Market Cap: 9.55 Bil Enterprise Value: 9.97 Bil PE Ratio: 110.35 PB Ratio: 2.83 GF Score: 85/100

Qiagen NV at Bank of America Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 01:10PM GMT
Release Date Price: €45.94 (-2.37%)
Derik de Bruin
BofA Securities, Inc. - Analyst

Good afternoon, everyone. This is Derik de Bruin, the senior life sciences and diagnostics tools analyst for Bank of America. Welcome to our virtual 2021 London healthcare conference. This morning, or this afternoon -- morning here in New York. This afternoon, we're happy to have Qiagen with us. And presenting for Qiagen is CEO, Thierry Bernard. Thierry, thank you for being here today; I appreciate your participation in the conference. And I guess to kick it off, any specific opening remarks you want to make, or we can jump right into Q&A?

Thierry Bernard
Qiagen N.V. - CEO & Managing Director

I mean I can start to -- basically a few words, Derik, if it's okay with you. And once again, thanks a lot from having Qiagen with you and for your interest in our Company. So I would just start saying that the weeks that have basically passed since we did our Q2 disclosure are proving me that I think Qiagen was right in communicating -- what we did communicate at the end of Q2.

First of all, that we still

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot